Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-548

I personally thought it was on point and polite.

Now, you've allowed your heightened suppostion to erroneously conclude they are "facts", when they are discussion points subject to..... arhhh evidence based discussion for the purposes of making an evidenced based decision. Neither of those two events have yet happened, have they?

Hardly atypical protocol for FDA approvals. If they were "facts" and a "decision" had been made, they wouldn't be having the meeting, would they?

Both of those questions are rhetorcial to save you the effort.